pharma
dog
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
News
when
Latest
Archive
by source
All Sources
Sources Page
Companies
by activity
Most Active
Biggest Pipelines
Recently Active
hiring
Companies Hiring Now
Big Pharma Roles
All Companies →
Drugs & Pipeline
intelligence
Drugs
Patent Cliff
research
Publications
Topics
Calendar
window
Next 90 Days
All (incl. Past)
by type
PDUFAs
Approvals
Earnings
Readouts
◐
Sign In
Subscribe
🐶
home
jobs
news
cal
search
GILEAD SCIENCES, INC. ($GILD) · pipeline · pharmadog
← back to GILEAD SCIENCES, INC.
Pipeline · $GILD
33
products
VEKLURY
VEKLURY (REMDESIVIR)
1 INDICATIONS AND USAGE VEKLURY is indicated for the treatment of coronavirus disease 2019 (COVID-19) in adults and pediatric patients (birth to less than 18 years of age weighing at least 1.5 kg) who are [see Clinical Studies (14) ] : Hospitalized, or Not hospitalized and have mild-to-moderate COVID-19, and are at high risk for progression to severe COVID-19, including hospitalization or death. VEKLURY is a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleotide analog RNA polymerase inhibitor indicated for the treatment of coronavirus disease 2019 (COVID-19) in adults and pediatric patients (birth to less than 18 years of age weighing at least 1.5 kg) who are: Hospitalized, or Not hospitalized and have mild-to-moderate COVID-19, and are at high risk for progression to severe COVID-19, including hospitalization or death. ( 1 )
pre_registration
bulevirtide
Hepatitis D
pre_registration
sacituzumab govitecan
Trodelvy (sacituzumab govitecan)
Triple-Negative Breast Cancer (TNBC)
← prev
page 2 of 2
next →
